WOLVERINE ASSET MANAGEMENT LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 151 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2017. The put-call ratio across all filers is 1.99 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$58,000
-93.5%
525,9060.0%0.00%
-100.0%
Q3 2018$893,000
-2.3%
525,9060.0%0.01%
-8.3%
Q2 2018$914,000
-1.4%
525,906
+3.7%
0.01%0.0%
Q1 2018$927,000
-13.7%
507,106
+5.2%
0.01%
+9.1%
Q4 2017$1,074,000
-17.2%
481,900
+7.7%
0.01%
-21.4%
Q3 2017$1,297,000
+229.2%
447,500
+403.9%
0.01%
+180.0%
Q2 2017$394,000
+14.9%
88,800
+20.3%
0.01%0.0%
Q1 2017$343,000
+419.7%
73,800
+570.9%
0.01%
+400.0%
Q4 2016$66,000
-40.5%
11,000
-45.5%
0.00%
-50.0%
Q3 2016$111,000
-86.9%
20,200
-86.6%
0.00%
-88.2%
Q4 2013$850,000
+111.4%
151,096
+71.4%
0.02%
+88.9%
Q3 2013$402,00088,1620.01%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2017
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders